Venus Remedies sees dip in stock price despite recent gains

Venus Remedies, a microcap pharmaceutical company, saw a dip in its stock price today after hitting a new 52-week high of Rs.429.6. The stock opened with a loss of -3.02% and underperformed the sector by -0.3%. This comes after two consecutive days of gains for the company's stock.

Despite the dip, Venus Remedies is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock in the long term.

In terms of performance, Venus Remedies has seen a -0.45% change in its stock price in the past day, while the Sensex has seen a 0.25% increase. Over the past month, Venus Remedies has outperformed the Sensex with a 7.50% increase compared to the Sensex's 3.94% increase.

It is worth noting that this news article is based solely on factual information and does not include any external data or sources. It is important for investors to conduct their own research and analysis before making any investment decisions. As a microcap company, Venus Remedies may have potential for growth, but it is important to consider all factors before investing.